ASX:AYA
ASX:AYAHealthcare Services

How Investors May Respond To Artrya (ASX:AYA) Raising A$80 Million for US FDA-Approved Salix Expansion

Artrya recently completed a major capital raise of A$80 million through follow-on equity offerings, aimed at supporting its US expansion after securing FDA approval for its AI-driven Salix coronary plaque detection device. This development underscores growing investor confidence in Artrya’s efforts to commercialize advanced medical technology in the lucrative US healthcare market. We'll explore how the FDA-approved rollout of Salix in the US contributes to Artrya's broader investment...
ASX:3PL
ASX:3PLConsumer Services

ASX Penny Stock Highlights For September 2025

Australian shares have been striving to align with Wall Street's bullish trends, as evidenced by the ASX 200 futures showing a positive uptick heading into Friday. This momentum comes amid broader market gains in the U.S., where indices like the S&P 500 and Dow Jones have reached new highs despite recent economic data challenges. In this context, penny stocks—though often considered niche investments—continue to offer intriguing opportunities for investors willing to explore beyond mainstream...